Gabelli Funds LLC Seagen Inc. Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $5.82 Million - $6.57 Million	30,378 Added 37.14%	112,178 $23.8 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $10.4 Million - $11.4 Million	55,500 Added 211.03%	81,800 $15.7 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $3.36 Million - $5.34 Million	26,300 New	26,300 $5.32 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $486,972 - $648,396	3,600 New	3,600 $493,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.